In the AD model induced by ICV injection of Aβ25–35, Sigma1R positive modulator OZP002, which has no ligand properties to Sigma1R but promotes chaperone activation, exhibited neuroprotective activity [186]. Here, SIGMAR1 is linked to Alzheimer disease.